Although the use of protein kinase inhibitors has been a successful strategy for treating a range of human cancers for many years, with 25 approved drugs to date33, to our knowledge it has not proved possible to exploit this target class to treat infectious disease. This evidence concerns the gene WEE1 and cancer.